Drug Shortage Report for JAMP AMOXI CLAV
Report ID | 223977 |
Drug Identification Number | 02508265 |
Brand name | JAMP AMOXI CLAV |
Common or Proper name | Amoxicillin and Clavulanate Potassium Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
Strength(s) | 125MG 875MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-03-29 |
Estimated end date | 2024-05-10 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-15 |
Company comments | Allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-04-15 | French | Compare |
v3 | 2024-04-15 | English | Compare |
v2 | 2024-03-30 | French | Compare |
v1 | 2024-03-30 | English | Compare |
Showing 1 to 4 of 4